AstraZeneca executives have told Fierce Biotech they still see potential in harnessing the relaxin hormone to treat heart failure despite abandoning work on one of two clinical-stage candidates. As ...

Moderna is currently developing an mRNA shot that aims to help the body produce relaxin, a hormone that can increase blood flow and potentially reduce the risk of a heart attack. Using the same ...